NoNO Inc.
$735,284.00 CAD
≈ 10 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- November 1, 2021 – May 31, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q4-984185
Published purpose
NoNO Inc. has developed and autoinjector compatible PSD95 inhibitor to provide neuroprotection that can be administered by any caregiver at home, enroute to the hospital or immediately upon arrival in the emergency department.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions